This Next-Gen Obesity Drug: Can It Save Novo Nordisk?
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Examine the tax effects of rebalancing a portfolio and practical ways to minimize tax impact. This intro covers common scenarios and planning ideas.
21,738 articlesNovo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Investors are pouring into autonomous weapons and defense tech, signaling a shift from software plays to hardware-dri...
Prospect Capital offers a striking 20%+ yield, but its long-run performance raises questions. This article lays out a...
When the chips slide, investors hunt for the best pick. This guide weighs Marvell and Broadcom as the market cools, o...
Olaplex shares exploded after Henkel announced a cash buyout. This piece breaks down what happened, why it matters fo...
A couple in their mid-60s weighs the cost of restoring classic cars against steady portfolio income as market conditi...
Nuclear energy stocks are poised for renewed interest in 2026 thanks to reliability, carbon-free power, and policy ta...
A 62-year-old with $1.4 million faces a five-year bridge to Social Security. Experts urge planners to treat this as a...
Rem’s Mortgage REIT Portfolio surged 19% over the past year as the Fed signaled a slower stance on rates, lifting inc...
A rising chorus of planners argues the fixed 4% rule may trap retirees in unnecessary caution. Experts say flexible w...
A veteran portfolio manager recounts selling a 19-bagger too early and explains how that misstep reshaped his long-te...
A single, moat-rich stock can anchor a long-term portfolio when you only have $1,500 to invest. This piece explains h...